Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 1/20 | 0.51 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.50 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.49 |
| ▸ | F13A1 | P00488 | 2/20 | 0.48 |
| ▸ | TGM2 | P21980 | 2/20 | 0.48 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.48 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.47 |
| ▸ | CCKBR | P32239 | 2/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | DPP3 | Q9NY33 | 3/20 | 0.46 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.46 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | CASP4 | P49662 | 1/20 | 0.46 |
| ▸ | CASP5 | P51878 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29904119 | 0.98 | MAGI3 (0.52) | CXCR4MAGI3PCSK9F13A1TGM2 | |
| SCHEMBL31191396 | 0.94 | CXCR4 (0.50) | CXCR4MAGI3PCSK9F13A1TGM2 | |
| SCHEMBL29776260 | 0.93 | DPP3 (0.49) | IL23RCCKBRDPP3NTSR2NTSR1 | |
| SCHEMBL31191419 | 0.90 | CXCR4 (0.53) | CXCR4MAGI3PCSK9F13A1TGM2 | |
| SCHEMBL31191387 | 0.90 | MAGI3 (0.55) | CXCR4MAGI3PCSK9F13A1TGM2 | |
| SCHEMBL15506563 | 0.90 | CXCR4 (0.50) | CXCR4MAGI3PCSK9F13A1TGM2 | |
| SCHEMBL31067243 | 0.89 | OPRD1 (0.54) | NTSR2NTSR1 | |
| SCHEMBL16924687 | 0.89 | MAGI3 (0.47) | CXCR4MAGI3F13A1TGM2IL23R | |
| SCHEMBL5497929 | 0.88 | GRPR (0.53) | CXCR4CCKBRNTSR2NTSR1SORT1 | |
| SCHEMBL31670608 | 0.85 | DPP3 (0.55) | CXCR4C5AR1DPP3NTSR2NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287147-A1 | PD-L1 BINDING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. | 2024-08-29 | — | — | US | disclosed |
| CN-109422799-B | Docetaxel liver cancer-resisting targeted prodrug and medicinal application thereof | 复旦大学 | 2022-07-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287147-A1 | PD-L1 BINDING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF | PDCD1LG2, CD274, PDCD1 | CXCR4 206/4885MAGI3 3900/4885PCSK9 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.